|
1
|
Poole AR, Rizkalla G, Ionescu M, Reiner A,
Brooks E, Rorabeck C, Bourne R and Bogoch E: Osteoarthritis in the
human knee: A dynamic process of cartilage matrix degradation,
synthesis and reorganization. Agents Actions Suppl. 39:3–13.
1993.PubMed/NCBI
|
|
2
|
Messier SP, Mihalko SL, Legault C, Miller
GD, Nicklas BJ, DeVita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein
F, et al: Effects of intensive diet and exercise on knee joint
loads, inflammation, and clinical outcomes among overweight and
obese adults with knee osteoarthritis: The IDEA randomized clinical
trial. JAMA. 310:1263–1273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abramson SB: Inflammation in
osteoarthritis. J Rheumatol Suppl. 70:70–76. 2004.PubMed/NCBI
|
|
4
|
Tao J, Cui Y, Duan Y, Zhang N, Wang C and
Zhang F: Puerarin attenuates locomotor and cognitive deficits as
well as hippocampal neuronal injury through the PI3K/Akt1/GSK-3β
signaling pathway in an in vivo model of cerebral ischemia.
Oncotarget. 8:106283–106295. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Cai W, Lee K, Liu B, Deng Y, Chen Y,
Zhang X, He JC and Zhong Y: Puerarin attenuates diabetic kidney
injury through the suppression of NOX4 expression in podocytes. Sci
Rep. 7:146032017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao J, Cheng Y, Yang C, Lau S, Lao L,
Shuai B, Cai J and Rong J: Botanical drug puerarin attenuates
6-hydroxydopamine (6-OHDA)-induced neurotoxicity via upregulating
mitochondrial enzyme arginase-2. Mol Neurobiol. 53:2200–2211. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu B, Zhao C, Li H, Chen X, Ding Y and Xu
S: Puerarin protects against heart failure induced by pressure
overload through mitigation of ferroptosis. Biochem Biophys Res
Commun. 497:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu H, Zhao M, Liang S, Huang Q, Xiao Y, Ye
L, Wang Q, He L, Ma L, Zhang H, et al: The effects of puerarin on
rat ventricular myocytes and the potential mechanism. Sci Rep.
6:354752016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Zhai Z, Zhou H, Li Y, Li X, Lin
Y, Li W, Shi Y and Zhou MS: Puerarin inhibits oxLDL-induced
macrophage activation and foam cell formation in human THP1
macrophage. Biomed Res Int. 2015:4036162015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu J, Wang X, Shang Y, Xie X, Zhang F,
Chen J and Fu G: Puerarin reduces endothelial progenitor cells
senescence through augmentation of telomerase activity. Vascul
Pharmacol. 49:106–110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo BQ, Xu JB, Xiao M, Ding M and Duan LJ:
Puerarin reduces ischemia/reperfusion-induced myocardial injury in
diabetic rats via upregulation of vascular endothelial growth
factor A/angiotensin-1 and suppression of apoptosis. Mol Med Rep.
17:7421–7427. 2018.PubMed/NCBI
|
|
12
|
Mercer LD, Kelly BL, Horne MK and Beart
PM: Dietary polyphenols protect dopamine neurons from oxidative
insults and apoptosis: Investigations in primary rat mesencephalic
cultures. Biochem Pharmacol. 69:339–345. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim J, Kim KM, Kim CS, Sohn E, Lee YM, Jo
K and Kim JS: Puerarin inhibits the retinal pericyte apoptosis
induced by advanced glycation end products in vitro and in vivo by
inhibiting NADPH oxidase-related oxidative stress. Free Radic Biol
Med. 53:357–365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu C, Chen B, Jin X, Liu X, Wang F, Guo R,
Chen Z, Zheng H, Wang L and Zhang Y: Puerarin protects endothelial
progenitor cells from damage of angiotensin II via activation of
ERK1/2Nrf2 signaling pathway. Mol Med Rep. 17:3877–3883.
2018.PubMed/NCBI
|
|
15
|
Deng Y, Lei T, Li H, Mo X, Wang Z and Ou
H: ERK5/KLF2 activation is involved in the reducing effects of
puerarin on monocyte adhesion to endothelial cells and
atherosclerotic lesion in apolipoprotein E-deficient mice. Biochim
Biophys Acta Mol Basis Dis. 1864:2590–2599. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JH, Jeon YD, Lee YM and Kim DK: The
suppressive effect of puerarin on atopic dermatitis-like skin
lesions through regulation of inflammatory mediators in vitro and
in vivo. Biochem Biophys Res Commun. 498:707–714. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tao Z, Ge Y, Zhou N, Wang Y, Cheng W and
Yang Z: Puerarin inhibits cardiac fibrosis via monocyte
chemoattractant protein (MCP)-1 and the transforming growth
factor-β1 (TGF-β1) pathway in myocardial infarction mice. Am J
Transl Res. 8:4425–4433. 2016.PubMed/NCBI
|
|
18
|
Wei HY, Zhang YJ and Zhao SZ: Puerarin
regulates neovascular glaucoma through pigment epitheliumderived
growth factorinduced NFkappaB signaling pathway. Mol Med Rep.
17:7866–7874. 2018.PubMed/NCBI
|
|
19
|
Liu X, Zhao W, Wang W, Lin S and Yang L:
Puerarin suppresses LPS-induced breast cancer cell migration,
invasion and adhesion by blockage NF-κB and Erk pathway. Biomed
Pharmacother. 92:429–436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amzaleg Y, Ji J, Kittivanichkul D, E
Törnqvist A, Windahl S, Sabag E, Khalid AB, Sternberg H, West M,
Katzenellenbogen JA, et al: Estrogens and selective estrogen
receptor modulators differentially antagonize Runx2 in ST2
mesenchymal progenitor cells. J Steroid Biochem Mol Biol.
183:10–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan SY, Sheng T, Liu LQ, Zhang YL, Liu
XM, Ma T, Zheng H, Yan Y, Ishimi Y and Wang XX: Puerarin prevents
bone loss in ovariectomized mice and inhibits osteoclast formation
in vitro. Chin J Nat Med. 14:265–269. 2016.PubMed/NCBI
|
|
22
|
Yang X, Zhang H, Wang J, Zhang Z and Li C:
Puerarin decreases bone loss and collagen destruction in rats with
ligature-induced periodontitis. J Periodontal Res. 50:748–757.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guingamp C, Gegout-Pottie P, Philippe L,
Terlain B, Netter P and Gillet P: Mono-iodoacetate-induced
experimental osteoarthritis: A dose-response study of loss of
mobility, morphology, and biochemistry. Arthritis Rheum.
40:1670–1679. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ueda MY, Alvarenga PG, Real JM, Moreira
Ede S, Watanabe A, Passos-Castilho AM, Vescovi M, Novis Y, Rocha V,
Seber A, et al: Optimisation of a quantitative polymerase chain
reaction-based strategy for the detection and quantification of
human herpesvirus 6 DNA in patients undergoing allogeneic
haematopoietic stem cell transplantation. Mem Inst Oswaldo Cruz.
110:461–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Raghu H, Lepus CM, Wang Q, Wong HH,
Lingampalli N, Oliviero F, Punzi L, Giori NJ, Goodman SB, Chu CR,
et al: CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment,
inflammation and cartilage destruction in osteoarthritis. Ann Rheum
Dis. 76:914–922. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeung DK, Leung SW, Xu YC, Vanhoutte PM
and Man RY: Puerarin, an isoflavonoid derived from Radix puerariae,
potentiates endothelium-independent relaxation via the cyclic AMP
pathway in porcine coronary artery. Eur J Pharmacol. 552:105–111.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao J, Luo D, Liang Z, Lao L and Rong J:
Plant natural product puerarin ameliorates depressive behaviors and
chronic pain in mice with spared nerve injury (SNI). Mol Neurobiol.
54:2801–2812. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Yan J, Xu X, Duan C, Xie Z, Su Z,
Ma H, Ma H, Wei X and Du X: Puerarin prevents LPS-induced acute
lung injury via inhibiting inflammatory response. Microb Pathog.
118:170–176. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu H, Zhao G, Jiang K, Chen X, Zhu Z, Qiu
C and Deng G: Puerarin exerts an antiinflammatory effect by
inhibiting NF-kB and MAPK activation in staphylococcus
aureus-induced mastitis. Phytother Res. 30:1658–1664. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deng HF, Wang S, Li L, Zhou Q, Guo WB,
Wang XL, Liu MD, Liu K and Xiao XZ: Puerarin prevents vascular
endothelial injury through suppression of NF-κB activation in
LPS-challenged human umbilical vein endothelial cells. Biomed
Pharmacother. 104:261–267. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tall AR and Yvan-Charvet L: Cholesterol,
inflammation and innate immunity. Nat Rev Immunol. 15:104–116.
2015. View
Article : Google Scholar : PubMed/NCBI
|
